HOME >> MEDICINE >> NEWS
Clinical guidelines for recalled pacemakers and implantable cardioverter-defibrillators developed

Richmond, Va. (July 25, 2006) A team of medical experts led by a Virginia Commonwealth University researcher has established a set of clinical guidelines to help physicians determine how to best care for patients with pacemakers or implantable cardioverter-defibrillators (ICDs) that are the subject of an advisory or recall.

The research team, led by Mitesh S. Amin, M.D., a resident in the Department of Internal Medicine at the VCU School of Medicine, developed the guidelines, which appear in the July 26 issue of the Journal of the American Medical Association.

"There is limited information to direct patient management after an implantable device has been subject to an FDA advisory," said Kenneth Ellenbogen, M.D., director of VCU's cardiac electrophysiology lab and senior author of the study. "These guidelines can give physicians a better understanding of the risks and benefits of device replacement compared to continued clinical follow-up."

In the analysis, the researchers considered the potential outcomes in deciding whether to immediately replace a device under advisory or to continue follow-up without replacement.

In determining the best management approach, the researchers constructed a decision analysis model to evaluate the risks and benefits associated with device replacement or continued monitoring.

The study considered variables including indications for device implantation, anticipated course following device failure, device failure rates from the advisory and device replacement mortality rates per procedure.

According to Ellenbogen, the findings suggest device replacement in the setting of an advisory is not inconsequential and frequently has a greater risk than continued device follow-up. The decision to replace a recalled device should be based primarily on the device failure rate, the degree of patient dependency and the anticipated mortality from device replacement.

"We ultimat
'"/>

Contact: Malorie Janis
mgjanis@vcu.edu
804-827-0889
Virginia Commonwealth University
25-Jul-2006


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
8. Clinical trial coordinators need more financial conflict-of-interest training
9. Clinical studies evaluate potential treatments for mouth ulcers
10. NIH names Clinical Trial Units for the Microbicide Trials Network
11. Clinical Trials Units selected for newly restructured HIV/AIDS research networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... and an accredited continuing medical education (CME) provider, is the official accreditor for ... reviewed presentations, vetted speakers, and screened topics, as it has done for the ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... Autopsies don’t ... damage or injury to the body. , Methamphetamine permanently harms the heart. It ... doctors are getting a better understanding of how the damage occurs. , ...
(Date:9/11/2019)... ... 2019 , ... Women’s Excellence is excited to announce the opening of their ... Suite 103, Royal Oak, MI 48073 in the heart of Royal Oak off Woodward ... services in a contemporary, spa-like atmosphere. We are thrilled to be in a ...
(Date:9/11/2019)... ... September 10, 2019 , ... Episcopal Relief & Development is ... impacted by Hurricane Dorian. , In partnership with the Episcopal Diocese of ... and the Episcopal Farmworker Ministry, Episcopal Relief & Development is giving assistance such ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... R&D, today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed ... nervous system, and other medical indications. , “As part of our strategy ...
(Date:9/11/2019)... ... September 11, 2019 , ... The Telehealth Secrets conference announces ... Naveen Jain, MDLIVE founder Randy Parker, NBC Comcast, senior vice president and general ... 4th Annual Telehealth Secrets conference brings together nationally recognized health innovators, thinkers, and ...
(Date:9/11/2019)... ... September 11, 2019 , ... HOLLOWAY AMERICA, a leading manufacturer of ... to pharma and chemical, recently announced it will showcase its problem-solving vessels and tanks ... , HOLLOWAY AMERICA’s first stop will be at ISPE San Diego’s 27th Life Science ...
Breaking Medicine Technology:
Cached News: